Login
| TI Ref No : | 528539855 |
|---|---|
| Description : | Conclusion Of Non-exclusive Agreements For Medicines With The Active Ingredient Fremanezumab (atc Code: N02cd03) Through An Open House Model |
| Date : | 2026-02-06 |
| Deadline : | 2026-08-05 |
| Document Type : | Tenders |
| TI Ref No : | 528539855 |
|---|---|
| Description : | Conclusion Of Non-exclusive Agreements For Medicines With The Active Ingredient Fremanezumab (atc Code: N02cd03) Through An Open House Model |
| Date : | 2026-02-06 |
| Deadline : | 2026-08-05 |
| Document Type : | Tenders |